These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33559307)

  • 1. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
    Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
    ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Zheng Z; Wang X; Lu X; Huang Y; Chi P
    Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
    Liao YT; Lin YL; Huang J; Hung JS; Lin BR
    Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients.
    Collard MK; Rullier E; Panis Y; Manceau G; Benoist S; Tuech JJ; Alves A; Laforest A; Mege D; Cazelles A; Beyer-Berjot L; Christou N; Cotte E; Lakkis Z; O'Connell L; Parc Y; Piessen G; Lefevre JH;
    Surgery; 2022 May; 171(5):1193-1199. PubMed ID: 35078629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
    Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
    Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.
    Sun Y; Zhang Y; Huang Z; Chi P
    J Gastrointest Surg; 2019 May; 23(5):1006-1014. PubMed ID: 30187336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy.
    Zhang H; Huang Y; Sun G; Zheng K; Lou Z; Gao XH; Hao LQ; Liu LJ; Meng RG; Zhang W
    Ann Transl Med; 2020 Jun; 8(12):743. PubMed ID: 32647668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy.
    Cui Y; Song M; Tie J; Li S; Wang H; Zhang Y; Geng J; Liu Z; Teng H; Sui X; Zhu X; Cai Y; Li Y; Wang W
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):176. PubMed ID: 38575793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inferior mesenteric artery lymph node metastasis in rectal cancer treated with neoadjuvant chemoradiotherapy: Incidence, prediction and prognostic impact.
    Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X
    Eur J Surg Oncol; 2017 Jan; 43(1):85-91. PubMed ID: 27717528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
    Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P
    J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy.
    Wang Y; Wang X; Huang S; Chen J; Huang Y
    ANZ J Surg; 2024 Jun; 94(6):1127-1132. PubMed ID: 38251776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Effects of Clinicopathological Features on Rectal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy.
    Arslan A; Akay E; Turk G; Eren SK
    J Coll Physicians Surg Pak; 2021 Apr; 31(4):422-428. PubMed ID: 33866728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer.
    Ozturk SK; Martinez CG; Mens D; Verhoef C; Tosetto M; Sheahan K; de Wilt JHW; Hospers GAP; van de Velde CJH; Marijnen CAM; van der Post RS; Nagtegaal ID
    Histopathology; 2024 May; 84(6):935-946. PubMed ID: 38192084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma.
    Kohl VKB; Weber K; Brunner M; Geppert CI; Fietkau R; Grützmann R; Semrau S; Merkel S
    Int J Colorectal Dis; 2022 Jun; 37(6):1355-1365. PubMed ID: 35545701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.